News
- Author:
- Jake Remaly
Publish date: May 6, 2020
Eight of the 15 gastrointestinal symptoms assessed were significantly increased in patients with Parkinson’s disease, relative to controls.
News
- Author:
- Jake Remaly
Publish date: May 1, 2020
During an open-label extension, patients who initially received placebo before switching to siponimod were more likely to have confirmed disability...
News
- Author:
- Jake Remaly
Publish date: April 30, 2020
The first case of PML directly associated with ocrelizumab occurred in a 78-year-old male with primary progressive MS.
News
- Author:
- Jake Remaly
Publish date: April 24, 2020
In a cohort of patients with dermatomyositis, 8% did not have a rash at the time of muscle biopsy.
News
- Author:
- Jake Remaly
Publish date: April 23, 2020
When suspecting axial spondyloarthritis, clinicians may need to wait at least 6 months after delivery to perform an MRI of the sacroiliac joints.
News
- Author:
- Jake Remaly
Publish date: April 14, 2020
A single-center study may have implications for the evaluation and care of patients with chronic obstructive pulmonary disease.
News
- Author:
- Jake Remaly
Publish date: April 10, 2020
Insurers should facilitate transitions to new preventive migraine therapies, including anti-CGRP monoclonal antibodies, headache specialists sugges...
News
- Author:
- Jake Remaly
Publish date: April 6, 2020
Pediatricians may need to expand their use of telehealth and work to minimize unintended effects of school closur...
News
- Author:
- Jake Remaly
Publish date: April 3, 2020
A randomized controlled trial finds that telephone-based cognitive behavioral therapy is effective and may be a convenient option for patients with...
News
- Author:
- Jake Remaly
Publish date: April 2, 2020
Potentially relevant drug interactions, how immunosuppressive medications may influence the risk of COVID-19, and neurologic diseases that may be a...
News
- Author:
- Jake Remaly
Publish date: April 1, 2020
The Danish health care system’s shift to adalimumab biosimilars led to substantial decreases in cost.
News
- Author:
- Jake Remaly
Publish date: March 31, 2020
The Danish health care system’s shift to adalimumab biosimilars led to substantial decreases in cost.
News
- Author:
- Jake Remaly
Publish date: March 30, 2020
“The inflammation-prone status of lesions may be the most important factor” for developing infection after undergoing endobronchial ultrasound-guid...
News
- Author:
- Jake Remaly
Publish date: March 27, 2020
Three neonates whose mothers had COVID-19 had elevated IgM antibody concentrations.
News
- Author:
- Jake Remaly
Publish date: March 26, 2020
GRAPEVINE, TEX. – The Arabin cervical pessary did not significantly affect the likelihood of preterm birth or a composite measure of adverse neonat...
